• Intel SAP other tech companies pledge to get more inclusive in hiring

    Computerworld | Intel, SAP, Lyft, Spotify and VMware are among more than 30 Silicon Valley companies to sign a pledge that they would take action to make their technology workforce "fully representative of the American people, as soon as possible."

    Jun 23, 2016

  • Buy-in from the top is key to cloud transitions AWS exec says

    Computerworld | As the head of Amazon Web Services, Andy Jassy has seen a lot of big organizations start using the public cloud. The biggest indicator of success for a cloud transition is simple, he says: Has the business' senior staff bought into it?

    Jun 22, 2016

  • Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

    Xconomy | Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with the CRISPR-Cas9 clinical trial.

    Jun 21, 2016

  • Illumina's Flatley speaks of genomic future

    The San Diego Union-Tribune | Illumina's Flatley speaks of genomic future. Longtime CEO stepping down to become chairman, looks for near-universal use of genome sequencing.

    Jun 21, 2016

  • Nvidias new Pascal GPU to supercharge deep learning

    Computerworld | Some of the world's fastest computers use Nvidia's graphics processor for computer vision and complex calculations, and a new GPU will supercharge these applications.

    Jun 20, 2016

  • Building Human Longevity’s Exhaustive Knowledgebase

    Bio-IT World | Best Practices Winner | Despite advances in genomics in the past decade, there are still large portions of the genome that scientists and physicians don’t know how to interpret. Human Longevity Inc. (HLI) wants to fill in those gaps.

    Jun 17, 2016

  • China claims exascale by 2020 three years before U.S.

    Computerworld | China's Tianhe-3 exascale system is set to go live in 2020, three years ahead of the US roadmap. But raw power aside, what might matter most in next-gen systems is how efficiently apps run.

    Jun 17, 2016

  • Rgenix Closes $33 Million Series B Round

    Bio-IT World Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33 million Series B financing led by Novo A/S and Sofinnova Partners, with participation from existing investors including Partnership Fund for New York City, Alexandria Venture Investments, and Conegliano Ventures LP. The financing will support clinical development of Rgenix’s lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline.

    Jun 15, 2016

  • NCI Launches GDC

    Bio-IT World The National Cancer Institute's new Genomic Data Commons platform aims to make genomic data publicly available in support of the “moonshot” to cure cancer.

    Jun 15, 2016

  • How iPS cells changed the world

    Nature News & Comment | Induced pluripotent stem cells were supposed to herald a medical revolution. But ten years after their discovery, they are transforming biological research instead.

    Jun 15, 2016

  • Survey Launch on Public Attitudes Toward Genomic Data Sharing

    Bio-IT World  | The Global Alliance for Genomics and Health (GA4GH) and the Wellcome Genome Campus have together launched a video series and survey to explore public attitudes toward genetic data handling.

    Jun 13, 2016

  • Gene Therapy Is Curing Hemophilia

    MIT Technology Review | Spark Therapeutics is turning gene-therapy experiments into real drugs.

    Jun 13, 2016

  • WorldQuant Backs Cycle Computings High-Performance Computing Play

    Fortune | Cycle Computing, which bootstrapped its high-performance computing cloud capabilities for 11 years, now has backing of WorldQuant Ventures.

    Jun 13, 2016

  • Heres what six storage suppliers will be doing for the next year or two

    The Register | At the Stifel technology conference, analyst Aaron Rakers, had some fireside chats with senior execs from Brocade and QLogic, Pure and Nimble, Seagate and WDC.

    Jun 10, 2016

  • AstraZeneca’s CI360 Wins Bio-IT World’s Knowledge Management Best Practices Award

    Bio-IT World | Best Practices Winner | Last April, Bio-IT World announced the winners of its Best Practices Awards in Boston. AstraZeneca came away this year as the big winner in the Knowledge Management category, impressing judges with their CI360 competitive intelligence platform. 

    Jun 10, 2016

  • Global Alliance for Genomics & Health Argues for Federated Data Ecosystem

    Bio-IT World | In a perspective article in the June 10 issue of Science (DOI: 10.1126/science.aaf6162), 31 authors from The Global Alliance for Genomics and Health challenged the genomics community to adopt a federated ecosystem for sharing genomic and clinical data.

    Jun 9, 2016

  • Omicia Closes $23 Million Series B

    Bio-IT World News Brief | Omicia today announced the completion of a $23 million Series B financing round. Several new investors participated in the round, including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large genomics investor, as well as existing investors ARTIS Ventures, Acadia Woods Partners and Buchanan Investments.

    Jun 8, 2016

  • IBM joins R Consortium

    Computerworld | IBM will back efforts to create infrastructure and best practices for the R community, as well as promote use of the language.

    Jun 6, 2016

  • Big Biotech is here — and its starting to look a lot like Big Pharma

    STAT | There are 17 biotech companies in the US that generate more than $500 million per year in revenue. And they're increasingly focused on buying innovative new products through mergers and acquisitions, rather than developing them in house.

    Jun 6, 2016

  • AIDS Grants Target HIV Persistence

    Bio-IT World News Brief | amfAR, The Foundation for AIDS Research, has awarded seven scientists a total of approximately $1.4 million in research grants to better understand why HIV persists in the body despite effective antiretroviral therapy (ART) and pursue novel pathways to a cure. This round of grants was supported in part by the Foundation for AIDS and Immune Research (FAIR).

    Jun 3, 2016